Sign in to view content

Health Disparities in Lapses in Diabetic Retinopathy Care

Cindy X Cai, MD

Video
Published 2023

Related

Protocol U: Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involv
Raj K. Maturi, MD
Updates from the Field
2017
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023
Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023

Category: Diabetic Retinopathy

See more